From post

(3)HMRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors

, , , , , , , , , и . Mol Pharmacol, 57 (5): 968-75 (мая 2000)Varani, K Merighi, S Gessi, S Klotz, K N Leung, E Baraldi, P G Cacciari, B Romagnoli, R Spalluto, G Borea, P A United states Molecular pharmacology Mol Pharmacol. 2000 May;57(5):968-75..

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed.

 

Другие публикации лиц с тем же именем

(3)HMRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors, , , , , , , , , и . Mol Pharmacol, 57 (5): 968-75 (мая 2000)Varani, K Merighi, S Gessi, S Klotz, K N Leung, E Baraldi, P G Cacciari, B Romagnoli, R Spalluto, G Borea, P A United states Molecular pharmacology Mol Pharmacol. 2000 May;57(5):968-75..Synthesis, biological activity, and molecular modeling investigation of new pyrazolo4,3-e-1,2,4-triazolo1,5-cpyrimidine derivatives as human A(3) adenosine receptor antagonists, , , , , , , , , и . J Med Chem, 45 (4): 770-80 (февраля 2002)Baraldi, Pier Giovanni Cacciari, Barbara Moro, Stefano Spalluto, Giampiero Pastorin, Giorgia Da Ros, Tatiana Klotz, Karl-Norbert Varani, Katia Gessi, Stefania Borea, Pier Andrea Research Support, Non-U.S. Gov't United States Journal of medicinal chemistry J Med Chem. 2002 Feb 14;45(4):770-80..Exploring potency and selectivity receptor antagonist profiles using a multilabel classification approach: the human adenosine receptors as a key study, , , , , , , , и . J Chem Inf Model, 49 (12): 2820-36 (декабря 2009)Michielan, Lisa Stephanie, Federico Terfloth, Lothar Hristozov, Dimitar Cacciari, Barbara Klotz, Karl-Norbert Spalluto, Giampiero Gasteiger, Johann Moro, Stefano Research Support, Non-U.S. Gov't United States Journal of chemical information and modeling J Chem Inf Model. 2009 Dec;49(12):2820-36..Synthesis, biological studies and molecular modeling investigation of 1,3-dimethyl-2,4-dioxo-6-methyl-8-(substituted) 1,2,3,4-tetrahydro 1,2,4-triazolo 3,4-f-purines as potential adenosine receptor antagonists, , , , , , , и . Farmaco, 60 (4): 299-306 (апреля 2005)Pastorin, Giorgia Bolcato, Chiara Cacciari, Barbara Kachler, Sonja Klotz, Karl-Norbert Montopoli, Christian Moro, Stefano Spalluto, Giampiero Research Support, Non-U.S. Gov't Italy Farmaco (Societa chimica italiana : 1989) Farmaco. 2005 Apr;60(4):299-306..Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: A complete structure-activity profile, , , , , , и . Purinergic Signal, 3 (3): 183-93 (июня 2007)Cacciari, Barbara Bolcato, Chiara Spalluto, Giampiero Klotz, Karl-Norbet Bacilieri, Magdalena Deflorian, Francesca Moro, Stefano Netherlands Purinergic signalling Purinergic Signal. 2007 Jun;3(3):183-93. Epub 2006 Nov 14..Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: Effect of the N-5 bond type on the affinity and selectivity at the four adenosine receptor subtypes, , , , , , , и . Purinergic Signal, 4 (1): 39-46 (марта 2008)Bolcato, Chiara Cusan, Claudia Pastorin, Giorgia Spalluto, Giampiero Cacciari, Barbara Klotz, Karl Norbert Morizzo, Erika Moro, Stefano Netherlands Purinergic signalling Purinergic Signal. 2008 Mar;4(1):39-46. Epub 2007 Jul 25..Synthesis, biological and modeling studies of 1,3-di-n-propyl-2,4-dioxo-6-methyl-8-(substituted) 1,2,3,4-tetrahydro 1,2,4-triazolo 3,4-f-purines as adenosine receptor antagonists, , , , , , , и . Farmaco, 60 (8): 643-51 (августа 2005)Pastorin, G Bolcato, C Cacciari, B Kachler, S Klotz, K-N Montopoli, C Moro, S Spalluto, G Research Support, Non-U.S. Gov't France Farmaco (Societa chimica italiana : 1989) Farmaco. 2005 Aug;60(8):643-51..Pyrazolo4,3-e1,2,4-triazolo1,5-cpyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists: influence of the chain at the N(8) pyrazole nitrogen, , , , , , , , , и 1 other автор(ы). J Med Chem, 43 (25): 4768-80 (декабря 2000)Baraldi, P G Cacciari, B Romagnoli, R Spalluto, G Moro, S Klotz, K N Leung, E Varani, K Gessi, S Merighi, S Borea, P A Research Support, Non-U.S. Gov't United states Journal of medicinal chemistry J Med Chem. 2000 Dec 14;43(25):4768-80..Pyrazolo4,3-e-1,2,4-triazolo1,5-cpyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists, , , , , , , , , и . J Med Chem, 42 (22): 4473-8 (ноября 1999)Baraldi, P G Cacciari, B Romagnoli, R Spalluto, G Klotz, K N Leung, E Varani, K Gessi, S Merighi, S Borea, P A In Vitro Research Support, Non-U.S. Gov't United states Journal of medicinal chemistry J Med Chem. 1999 Nov 4;42(22):4473-8..Combining selectivity and affinity predictions using an integrated Support Vector Machine (SVM) approach: An alternative tool to discriminate between the human adenosine A(2A) and A(3) receptor pyrazolo-triazolo-pyrimidine antagonists binding sites, , , , , , , , , и 2 other автор(ы). Bioorg Med Chem, 17 (14): 5259-74 (июля 2009)Michielan, Lisa Bolcato, Chiara Federico, Stephanie Cacciari, Barbara Bacilieri, Magdalena Klotz, Karl-Norbert Kachler, Sonja Pastorin, Giorgia Cardin, Riccardo Sperduti, Alessandro Spalluto, Giampiero Moro, Stefano Research Support, Non-U.S. Gov't England Bioorganic & medicinal chemistry Bioorg Med Chem. 2009 Jul 15;17(14):5259-74. Epub 2009 May 21..